‘Tarlatamab’s FDA approval: shaping the future of cancer therapy’
Authors:
- Iqra Mbbs AlamgirIAIqra Mbbs Alamgir
- Unsa Mbbs AlamgirUAUnsa Mbbs Alamgir
- Eman Mbbs AlamgirEAEman Mbbs Alamgir
- Ayaan Ahmed Mbbs QureshiAQAyaan Ahmed Mbbs Qureshi
- Muhammad Osama Mbbs SiddiquiMSMuhammad Osama Mbbs Siddiqui
- Mohammed Hammad Mbbs JaberMJMohammed Hammad Mbbs Jaber
- Jatin Mbbs MotwaniJMJatin Mbbs Motwani
Open Access
- 10 September 2024
- journal article
- editorial
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (10) , 5676-5679
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 15 references indexed in Scilit:
- Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?Journal of Clinical Oncology, 2023
- Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I StudyJournal of Clinical Oncology, 2023
- AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung CancerClinical Cancer Research, 2021
- Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerNature Cancer, 2020
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trialThe Lancet, 2019
- Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancerJournal of Hematology & Oncology, 2019
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerNew England Journal of Medicine, 2018
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancerNature, 2017
- Different assemblies of Notch receptors coordinate the distribution of the major bronchial Clara, ciliated and neuroendocrine cellsDevelopment, 2012
- Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment ParadigmsThe Oncologist, 2010